Up to 10,000 strokes 'could be preventable'
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Up to 10,000 major strokes a year could be prevented if the early warning signs in susceptible individuals were assessed and treated rapidly, doctors say today.
Two research groups in France and Britain have found that early treatment of people who suffer a minor stroke, also known as a transient ischaemic attack (TIA), can cut the risk of a major stroke by 80 per cent.
The treatment is cheap and simple – often a daily dose of aspirin will be enough – but the speed with which it is administered is the key to its success.
In the British study, researchers at the Radcliffe Infirmary, Oxford, compared patients referred to a specialist clinic for assessment and then sent back to their GP for treatment, who waited 23 days for their pills, with a second group who were assessed and treated within a day.
The results showed 10.3 per cent of the first group suffered a major stroke within the next three months, compared to 2.1 per cent of the rapidly treated group.
The French researchers also found an 80 per cent reduction in risk with rapid treatment.
The studies are published in The Lancet and The Lancet Neurology.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments